<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Lynkogen Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=31161></link><description><![CDATA[Lynkogen Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sun, 26 Apr 2026 11:56:40 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2018/07/12_3698601005_20180702094721_3098163823.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Alteogen and Lynkogen Expand Agreement to Include Additional Proprietary Fusion Proteins Targeting NASH]]></title><link>https://www.newswire.co.kr/newsRead.php?no=880015</link><description><![CDATA[DAEJEON, South Korea & EAST WINDSOR, N.J.--(Business Wire/Korea Newswire)--Alteogen Inc. (196170.KQ) and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. In addition to the originally announced GLP-1 mimetic fusion proteins, Lynkogen will also acquire exclusive rights to FGF21 fusions, including dual function FGF21/GLP-1 mimetic fusion protein. Lynkogen and Alteogen w...]]></description><pubDate>Tue, 04 Dec 2018 09:05:00 +0900</pubDate></item><item><title><![CDATA[Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases]]></title><link>https://www.newswire.co.kr/newsRead.php?no=871723</link><description><![CDATA[DAEJEON, Korea & EAST WINDSOR, N.J.--(Business Wire/Korea Newswire)--Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive option agreement for the development of Alteogen’s novel GLP-1 mimetic and Alpha-1 Antitrypsin (A1AT) fusion proteins based on their proprietary NexP™ fusion technology to tackle NASH and metabolic diseases. Under the terms of the agreement L...]]></description><pubDate>Mon, 02 Jul 2018 10:00:00 +0900</pubDate></item></channel></rss>